Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis During Radiotherapy for Head and Neck Cancer.

@article{Giacomelli2015OralLM,
  title={Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis During Radiotherapy for Head and Neck Cancer.},
  author={Irene Giacomelli and Daniele Scartoni and Meacci Fiammetta and Muhammed Baki and Giacomo Zei and Cristina Muntoni and Sabrina Cappelli and Daniela Greto and Silvia Scoccianti and Lorenzo Livi},
  journal={Nutrition and cancer},
  year={2015},
  volume={67 8},
  pages={
          1247-53
        }
}
The aim of our Phase II study is to demonstrate the benefits, safety, and tolerance of Orasol Plus, an easy and feasible Lapacho-based medication. Orasol Plus is a nutritional, swallowable solution, useful to support the defenses of the oropharyngeal mucosa. Between January and June 2014, 40 consecutive adult patients affected by head and neck cancer were enrolled. Orasol Plus was administered 3 times a day from the first day till the end of radiotherapy. Primary endpoint was to evaluate… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

A phase III trial of radiotherapy plus cetuximab versus chemoradiotherapy in HPV-associated oropharynx cancer

A Trotti, M Gillison
  • RTOG 1016,
  • 2014
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…